563 related articles for article (PubMed ID: 9741514)
21. [Antiarrhythmia agents in heart failure].
Duc P
Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):595-8. PubMed ID: 7487307
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of amiodarone in patients with atrial fibrillation with and without left ventricular dysfunction: a pooled analysis of AFFIRM and AF-CHF trials.
Cadrin-Tourigny J; Wyse DG; Roy D; Blondeau L; Levesque S; Talajic M; Andrade JG; Dubuc M; Thibault B; Guerra PG; Macle L; Rivard L; Khairy P
J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1306-13. PubMed ID: 25181386
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
Yan RT; White M; Yan AT; Yusuf S; Rouleau JL; Maggioni AP; Hall C; Latini R; Afzal R; Floras J; Masson S; McKelvie RS;
Am J Cardiol; 2005 Sep; 96(5):698-704. PubMed ID: 16125499
[TBL] [Abstract][Full Text] [Related]
24. Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program.
Joglar JA; Acusta AP; Shusterman NH; Ramaswamy K; Kowal RC; Barbera SJ; Hamdan MH; Page RL
Am Heart J; 2001 Sep; 142(3):498-501. PubMed ID: 11526364
[TBL] [Abstract][Full Text] [Related]
25. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction.
Exner DV; Dries DL; Domanski MJ; Cohn JN
N Engl J Med; 2001 May; 344(18):1351-7. PubMed ID: 11333991
[TBL] [Abstract][Full Text] [Related]
26. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening?
Ho SF; O'Mahony MS; Steward JA; Burr ML; Buchalter M
Age Ageing; 2004 Sep; 33(5):488-92. PubMed ID: 15271642
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients.
Dries DL; Strong MH; Cooper RS; Drazner MH
J Am Coll Cardiol; 2002 Jul; 40(2):311-7. PubMed ID: 12106937
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy.
Pedersen OD; Bagger H; Keller N; Marchant B; Køber L; Torp-Pedersen C
Circulation; 2001 Jul; 104(3):292-6. PubMed ID: 11457747
[TBL] [Abstract][Full Text] [Related]
29. Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.
Schmiegelow MD; Pedersen OD; Køber L; Seibæk M; Abildstrøm SZ; Torp-Pedersen C
BMC Cardiovasc Disord; 2011 May; 11():19. PubMed ID: 21569543
[TBL] [Abstract][Full Text] [Related]
30. The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited.
Parker AB; Yusuf S; Naylor CD
Am Heart J; 2002 Dec; 144(6):941-7. PubMed ID: 12486418
[TBL] [Abstract][Full Text] [Related]
31. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
Konstam MA; Kronenberg MW; Rousseau MF; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
Circulation; 1993 Nov; 88(5 Pt 1):2277-83. PubMed ID: 8222122
[TBL] [Abstract][Full Text] [Related]
32. Does atrial fibrillation in elderly patients with chronic heart failure limit the efficacy of carvedilol? Suggestions from an observational study.
Opasich C; De Feo S; Cioffi G; Pulignano G; Del Sindaco D; Tarantini L; Gualco A; Patrignani A
Ital Heart J; 2005 Apr; 6(4):323-7. PubMed ID: 15902931
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: a retrospective cohort study.
Zhao Q; Wang L; Kurlansky PA; Schein J; Baser O; Berger JS
BMC Cardiovasc Disord; 2019 Jan; 19(1):19. PubMed ID: 30646855
[TBL] [Abstract][Full Text] [Related]
34. Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve).
Böhm M; Perez AC; Jhund PS; Reil JC; Komajda M; Zile MR; McKelvie RS; Anand IS; Massie BM; Carson PE; McMurray JJ;
Eur J Heart Fail; 2014 Jul; 16(7):778-87. PubMed ID: 24864045
[TBL] [Abstract][Full Text] [Related]
35. Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials.
de Denus S; Tardif JC; White M; Bourassa MG; Racine N; Levesque S; Ducharme A
Am Heart J; 2006 Oct; 152(4):705-12. PubMed ID: 16996842
[TBL] [Abstract][Full Text] [Related]
36. [Dofetilide to patients with heart failure and left ventricular dysfunction].
Torp-Pedersen CT; Møller M; Bloch-Thomsen PE; Køber L; Sandøe E; Egstrup K; Agner E; Carlsen JE; Videbaek J
Ugeskr Laeger; 2000 Oct; 162(44):5948-53. PubMed ID: 11094565
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin converting enzyme inhibition in asymptomatic left ventricular systolic dysfunction and early heart failure.
Konstam MA
Eur Heart J; 1995 Dec; 16 Suppl N():59-64. PubMed ID: 8682063
[TBL] [Abstract][Full Text] [Related]
38. Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation.
Nieuwlaat R; Eurlings LW; Cleland JG; Cobbe SM; Vardas PE; Capucci A; López-Sendòn JL; Meeder JG; Pinto YM; Crijns HJ
J Am Coll Cardiol; 2009 May; 53(18):1690-8. PubMed ID: 19406345
[TBL] [Abstract][Full Text] [Related]
39. Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD).
Vermes E; Ducharme A; Bourassa MG; Lessard M; White M; Tardif JC;
Circulation; 2003 Mar; 107(9):1291-6. PubMed ID: 12628950
[TBL] [Abstract][Full Text] [Related]
40. Impact of initial heart failure emergence on clinical outcomes of atrial fibrillation patients in the AFFIRM trial.
Slee A; Saksena S
Am Heart J; 2020 Feb; 220():1-11. PubMed ID: 31756389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
